SOPs for Liposome and Emulsion Formulations

The purpose of this SOP is to outline the procedure for incorporating active pharmaceutical ingredients (APIs) into emulsion formulations. Emulsions are used to deliver both hydrophilic and lipophilic APIs, enhancing solubility and stability, which can improve bioavailability and controlled release.
Click to read the full article.

The purpose of this SOP is to describe the procedure for formulating transdermal emulsions, which are designed to deliver active pharmaceutical ingredients (APIs) through the skin. Transdermal emulsions provide a non-invasive route of drug administration, allowing for sustained and controlled release of APIs over time.
Click to read the full article.

The purpose of this SOP is to outline the procedure for preparing liposomes for nasal delivery. Nasal liposomes are used for delivering active pharmaceutical ingredients (APIs) directly to the nasal mucosa, enabling targeted drug delivery with potential systemic absorption. This formulation method is particularly useful for treatments involving neurological conditions or local nasal therapies.
Click to read the full article.

The purpose of this SOP is to outline the procedure for preparing emulsions for oral delivery. Oral emulsions are designed to improve the solubility and bioavailability of poorly water-soluble drugs by dispersing the drug in an oil-in-water or water-in-oil emulsion for effective gastrointestinal absorption.
Click to read the full article.

The purpose of this SOP is to outline the procedure for formulating heat-sensitive liposomes, which are designed to release their encapsulated contents in response to specific temperature conditions. These liposomes are used in targeted drug delivery applications, particularly in hyperthermic therapies, where localized heating can trigger drug release.
Click to read the full article.

The purpose of this SOP is to outline the procedure for conducting physical stability studies on liposomal formulations. Physical stability studies are critical to ensure that liposomes retain their structural integrity, particle size distribution, and colloidal stability over time under different storage conditions. This helps in determining the shelf life and suitability of the formulation for clinical or commercial use.
Click to read the full article.

The purpose of this SOP is to describe the process for conducting physical stability studies on emulsions. Physical stability is essential to ensure that emulsions maintain their homogeneity, droplet size distribution, and absence of phase separation over time under various storage conditions. This helps establish the shelf life and suitability of emulsions for commercial or clinical use.
Click to read the full article.

The purpose of this SOP is to outline the procedure for conducting accelerated stability testing on liposome formulations. This type of testing simulates long-term storage conditions by exposing the formulation to elevated temperatures and humidity levels over a short period. The goal is to predict the shelf life and stability of the liposomal product by observing physical and chemical changes under stress conditions.
Click to read the full article.

The purpose of this SOP is to describe the procedure for conducting accelerated stability testing on emulsion formulations. This testing simulates long-term storage conditions by exposing the emulsion to elevated temperatures and humidity levels over a short period. It helps predict the shelf life of the formulation by observing changes in physical and chemical stability under stress conditions.
Click to read the full article.

The purpose of this SOP is to outline the procedure for conducting chemical stability testing on liposome formulations. Chemical stability testing evaluates the integrity of the active pharmaceutical ingredient (API) and the excipients within the liposomal formulation over time, ensuring that no degradation products or other chemical changes compromise the product’s efficacy or safety.
Click to read the full article.